Abstract
Apparent blood–brain barrier (BBB) disruption is common in glioblastoma (GBM), but has not translated to improved drug delivery efficacy. Recently, de Gooijer et al. demonstrated that efflux transporters can have a prominent role in limiting drug delivery. These transport systems contribute to ineffective drug delivery to tumor cells in the brain.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 426-428 |
| Number of pages | 3 |
| Journal | Trends in Pharmacological Sciences |
| Volume | 42 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2021 |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Ltd
PubMed: MeSH publication types
- Journal Article
- Comment
Fingerprint
Dive into the research topics of 'Efflux Limits Tumor Drug Delivery Despite Disrupted BBB'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS